Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending ...

The cohort's mean age was 49 years; just over half were female; and the most common health conditions of interest were dyslipidemia (24.5%), hypertension (23.2%), a mental health disorder (15.5%), ...

Molly O’Shea, MD, FAAP, shares insights on MMR coverage, measles outbreaks, and the pharmacist’s role from the perspective of a pediatrician.

In this episode of Wicked Good Cardiometabolic Chat, hosts Hailey Choi, PharmD, BCACP, CDCES, and Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professors of pharmacy practice at the Massachusetts ...

Pharmacists find themselves on the front lines of a growing public health challenge as measles cases surge nationwide. As ...

Adults older than 55 years with overweight or obesity, but without type 2 diabetes, who started tirzepatide (Zepbound) had ...

Eli Lilly and Company announced new phase 3b data, showing that combining ixekizumab (Taltz) with tirzepatide (Zepbound) produced improved and durable efficacy at 1 year in adults with psoriatic ...

In "COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients," moderator Jeff Goad, PharmD, MPH is joined by ...

Lifestyle counseling is described as passive and referral-oriented, highlighting an implementation gap for proactive risk ...

A SMART-design, pragmatic trial in 20,604 adults showed digital outreach improved 14-day statin refill rates versus usual ...

The FDA approved tirzepatide (Mounjaro) for lowering the risk of major adverse cardiovascular events (MACE) among adults with ...

Women showed consistently higher post-T2D mental health diagnoses, with the strongest signal in younger women, supporting ...